{"transactions":[{"id":700643,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-30T20:07:25.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest on the earlier of (i) July 28, 2027 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":25000,"derivative":{"exercise_price":2.14,"expiration_date":"2036-07-28","underlying":"Class A Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001239757-26-000002","document":"form4-07302026_080717.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000123975726000002/form4-07302026_080717.xml","form_type":"4"}},{"id":700642,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-07-30T20:07:25.000Z","date":"2026-07-28","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) July 28, 2027 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":821025,"source":{"system":"sec-edgar","filing":"0001239757-26-000002","document":"form4-07302026_080717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000123975726000002/form4-07302026_080717.xml","form_type":"4"}},{"id":1090013,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-09T20:10:22.000Z","date":"2025-07-07","kind":"grant","planned":false,"acquired":true,"shares":30500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest on the earlier of (i) July 7, 2026 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":30500,"derivative":{"exercise_price":2.18,"expiration_date":"2035-07-07","underlying":"Class A Common Stock","underlying_shares":30500},"source":{"system":"sec-edgar","filing":"0001415889-25-019571","document":"form4-07092025_080719.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000141588925019571/form4-07092025_080719.xml","form_type":"4"}},{"id":1090012,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-07-09T20:10:22.000Z","date":"2025-07-07","kind":"grant","planned":false,"acquired":true,"shares":20500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) July 7, 2026 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":804525,"source":{"system":"sec-edgar","filing":"0001415889-25-019571","document":"form4-07092025_080719.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000141588925019571/form4-07092025_080719.xml","form_type":"4"}},{"id":1479077,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2024-06-14T20:25:29.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":58178,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 12, 2025 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":784025,"source":{"system":"sec-edgar","filing":"0001415889-24-016912","document":"form4-06142024_080624.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000141588924016912/form4-06142024_080624.xml","form_type":"4"}},{"id":1524790,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-07T20:51:51.000Z","date":"2024-05-06","kind":"grant","planned":false,"acquired":true,"shares":7557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will become fully vested and exercisable on the earlier of May 6, 2025, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service."}],"balance_after":7557,"derivative":{"exercise_price":122.13,"expiration_date":"2034-05-06","underlying":"Common Stock","underlying_shares":7557},"source":{"system":"sec-edgar","filing":"0001127602-24-014459","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760224014459/form4.xml","form_type":"4"}},{"id":1852399,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-17T01:18:12.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":34735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest on the earlier of (i) June 14, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":34735,"derivative":{"exercise_price":4.33,"expiration_date":"2033-06-14","underlying":"Class A Common Stock","underlying_shares":34735},"source":{"system":"sec-edgar","filing":"0001209191-23-038193","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919123038193/doc4.xml","form_type":"4"}},{"id":1852398,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2023-06-17T01:18:12.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":23443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 14, 2024 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":725847,"source":{"system":"sec-edgar","filing":"0001209191-23-038193","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919123038193/doc4.xml","form_type":"4"}},{"id":1902784,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-05-05T20:12:38.000Z","date":"2023-05-03","kind":"grant","planned":false,"acquired":true,"shares":6134,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will become fully vested and exercisable on the earlier of May 3, 2024, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service."}],"balance_after":6134,"derivative":{"exercise_price":130.14,"expiration_date":"2033-05-03","underlying":"Common Stock","underlying_shares":6134},"source":{"system":"sec-edgar","filing":"0001127602-23-014678","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760223014678/form4.xml","form_type":"4"}},{"id":2033018,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-02-03T21:34:21.000Z","date":"2022-05-05","kind":"gift","acquired":false,"shares":703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported disposition represents a bona fide charitable gift made by the reporting person."}],"balance_after":11466961,"source":{"system":"sec-edgar","filing":"0001127602-23-003341","document":"form5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760223003341/form5.xml","form_type":"5"}},{"id":2178202,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true}}],"security":"Stock Option","published_at":"2022-08-19T20:07:28.000Z","date":"2022-08-17","kind":"disposition_to_issuer","acquired":false,"shares":14846,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 17, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vests in full on the earlier of June 17, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders."}],"balance_after":0,"derivative":{"exercise_price":10.14,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":14846},"source":{"system":"sec-edgar","filing":"0001127602-22-021379","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1239757/000112760222021379/form4.xml","form_type":"4"}},{"id":2178201,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true}}],"security":"Stock Option","published_at":"2022-08-19T20:07:28.000Z","date":"2022-08-17","kind":"grant","acquired":true,"shares":14846,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 17, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vested in full on the earlier of June 17, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders."}],"balance_after":14846,"derivative":{"exercise_price":2.14,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":14846},"source":{"system":"sec-edgar","filing":"0001127602-22-021379","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1239757/000112760222021379/form4.xml","form_type":"4"}},{"id":2178200,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true}}],"security":"Stock Option","published_at":"2022-08-19T20:07:28.000Z","date":"2022-08-17","kind":"disposition_to_issuer","acquired":false,"shares":14846,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 17, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests in full on the earlier of June 11, 2021 or the day immediately prior to the company's 2021 annual meeting of shareholders."}],"balance_after":0,"derivative":{"exercise_price":18.63,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":14846},"source":{"system":"sec-edgar","filing":"0001127602-22-021379","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1239757/000112760222021379/form4.xml","form_type":"4"}},{"id":2178199,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true}}],"security":"Stock Option","published_at":"2022-08-19T20:07:28.000Z","date":"2022-08-17","kind":"grant","acquired":true,"shares":14846,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The transaction reported herein reflects a one-time stock option repricing that became effective on August 17, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vested in full on the earlier of June 11, 2021 or the day immediately prior to the company's 2021 annual meeting of shareholders."}],"balance_after":14846,"derivative":{"exercise_price":2.14,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":14846},"source":{"system":"sec-edgar","filing":"0001127602-22-021379","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239757/000112760222021379/form4.xml","form_type":"4"}},{"id":2222918,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true}}],"security":"Stock Option","published_at":"2022-06-23T20:12:19.000Z","date":"2022-06-21","kind":"grant","acquired":true,"shares":14846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 21, 2023 or the day immediately prior to the company's 2023 annual meeting of shareholders."}],"balance_after":14846,"derivative":{"exercise_price":1.17,"expiration_date":"2032-06-20","underlying":"Common Stock","underlying_shares":14846},"source":{"system":"sec-edgar","filing":"0001127602-22-018032","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239757/000112760222018032/form4.xml","form_type":"4"}},{"id":2228010,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T22:42:52.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":29640,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Shares subject to the option vest on the earlier of (i) June 15, 2023 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":29640,"derivative":{"exercise_price":7.33,"expiration_date":"2032-06-15","underlying":"Class A Common Stock","underlying_shares":29640},"source":{"system":"sec-edgar","filing":"0001209191-22-038112","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919122038112/doc4.xml","form_type":"4"}},{"id":2228009,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-06-17T22:42:52.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":9945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) June 15, 2023 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":702404,"source":{"system":"sec-edgar","filing":"0001209191-22-038112","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919122038112/doc4.xml","form_type":"4"}},{"id":2286513,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-02T20:45:52.000Z","date":"2022-04-28","kind":"grant","acquired":true,"shares":5415,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This option will become fully vested and exercisable on the earlier of April 28, 2023, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service."}],"balance_after":5415,"derivative":{"exercise_price":142.52,"underlying":"Common Stock","underlying_shares":5415},"source":{"system":"sec-edgar","filing":"0001127602-22-012860","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760222012860/form4.xml","form_type":"4"}},{"id":2286512,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-02T20:45:52.000Z","date":"2022-04-28","kind":"exercise","acquired":false,"shares":703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this restricted stock unit award vested in full on April 28, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares subject to this restricted stock unit award vested in full on April 28, 2022."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":703},"source":{"system":"sec-edgar","filing":"0001127602-22-012860","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760222012860/form4.xml","form_type":"4"}},{"id":2286511,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-02T20:45:52.000Z","date":"2022-04-28","kind":"exercise","acquired":true,"shares":703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":11467664,"source":{"system":"sec-edgar","filing":"0001127602-22-012860","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760222012860/form4.xml","form_type":"4"}},{"id":2436859,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class B Common Stock","published_at":"2022-01-12T23:44:23.000Z","date":"2022-01-10","kind":"exercise","acquired":false,"shares":327102,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":327102},"source":{"system":"sec-edgar","filing":"0001209191-22-003127","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919122003127/doc4.xml","form_type":"4"}},{"id":2436858,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2022-01-12T23:44:23.000Z","date":"2022-01-10","kind":"exercise","acquired":true,"shares":327102,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Class B Common Stock is convertible at any time into Class A Common Stock on a one-to-one basis at the reporting person's election and has no expiration date."}],"balance_after":692459,"source":{"system":"sec-edgar","filing":"0001209191-22-003127","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919122003127/doc4.xml","form_type":"4"}},{"id":2658939,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-22T22:32:14.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest on the earlier of (i) June 17, 2022 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders."}],"balance_after":15000,"derivative":{"exercise_price":33.74,"expiration_date":"2031-06-17","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-21-042507","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000120919121042507/doc4.xml","form_type":"4"}},{"id":2660564,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true}}],"security":"Stock Option","published_at":"2021-06-21T20:34:26.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":14846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 17, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders."}],"balance_after":14846,"derivative":{"exercise_price":10.14,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":14846},"source":{"system":"sec-edgar","filing":"0001127602-21-020416","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239757/000112760221020416/form4.xml","form_type":"4"}},{"id":2734538,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-04-30T20:12:05.000Z","date":"2021-04-28","kind":"grant","acquired":true,"shares":703,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this restricted stock unit award will vest in full on the earlier of April 28, 2022, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares subject to this restricted stock unit award will vest in full on the earlier of April 28, 2022, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service."}],"balance_after":703,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":703},"source":{"system":"sec-edgar","filing":"0001127602-21-014774","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760221014774/form4.xml","form_type":"4"}},{"id":2734537,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-30T20:12:05.000Z","date":"2021-04-28","kind":"grant","acquired":true,"shares":4081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will become fully vested and exercisable on the earlier of April 28, 2022, or Moderna's next Annual Meeting of Stockholders, subject to the recipient's continued service."}],"balance_after":4081,"derivative":{"exercise_price":178.68,"expiration_date":"2031-04-28","underlying":"Common Stock","underlying_shares":4081},"source":{"system":"sec-edgar","filing":"0001127602-21-014774","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760221014774/form4.xml","form_type":"4"}},{"id":2948752,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-12T02:11:27.000Z","date":"2020-12-03","kind":"grant","acquired":true,"shares":18691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares subject to the option vest in 36 equal monthly installments beginning on January 3, 2021."}],"balance_after":18691,"derivative":{"exercise_price":19,"expiration_date":"2020-12-03","underlying":"Class A Common Stock","underlying_shares":18691},"source":{"system":"sec-edgar","filing":"0001628280-20-017430","document":"wf-form4_160773906729638.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000162828020017430/wf-form4_160773906729638.xml","form_type":"4"}},{"id":2951900,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2020-12-10T01:23:36.000Z","date":"2020-12-08","kind":"exercise","acquired":false,"shares":205831,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":205831},"source":{"system":"sec-edgar","filing":"0001628280-20-017317","document":"wf-form4_160756340152405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000162828020017317/wf-form4_160756340152405.xml","form_type":"4"}},{"id":2951899,"issuer":{"id":6717,"kind":"organization","name":"Seer, Inc.","symbol":"SEER"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2020-12-10T01:23:36.000Z","date":"2020-12-08","kind":"exercise","acquired":true,"shares":205831,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock automatically converted into Class A Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock and had no expiration date."}],"balance_after":365357,"source":{"system":"sec-edgar","filing":"0001628280-20-017317","document":"wf-form4_160756340152405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1726445/000162828020017317/wf-form4_160756340152405.xml","form_type":"4"}},{"id":2972907,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-11-19T22:55:07.000Z","date":"2020-11-17","kind":"gift","acquired":false,"shares":56912,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":214326,"source":{"system":"sec-edgar","filing":"0001127602-20-029622","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239757/000112760220029622/form4.xml","form_type":"4"}},{"id":3111584,"issuer":{"id":6388,"kind":"organization","name":"Korro Bio, Inc.","symbol":"KRRO"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true}}],"security":"Stock Option","published_at":"2020-06-12T11:24:44.000Z","date":"2020-06-11","kind":"grant","acquired":true,"shares":14846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in full on the earlier of June 11, 2021 or the day immediately prior to the company's 2021 annual meeting of shareholders."}],"balance_after":14846,"derivative":{"exercise_price":18.63,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":14846},"source":{"system":"sec-edgar","filing":"0001127602-20-019480","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239757/000112760220019480/form4.xml","form_type":"4"}},{"id":3159295,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1/A Convertible Preferred Stock","published_at":"2020-05-06T23:31:08.000Z","date":"2020-05-05","kind":"exercise","acquired":false,"shares":23057,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":668},"source":{"system":"sec-edgar","filing":"0000899243-20-012170","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1239757/000089924320012170/doc4.xml","form_type":"4"}},{"id":3159294,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-06T23:31:08.000Z","date":"2020-05-05","kind":"exercise","acquired":true,"shares":668,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock was automatically converted into 0.0289998 shares of common stock upon the closing of the Issuer's initial public offering. The preferred stock had no expiration date."}],"balance_after":15167,"source":{"system":"sec-edgar","filing":"0000899243-20-012170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239757/000089924320012170/doc4.xml","form_type":"4"}},{"id":3165254,"issuer":{"id":46837,"kind":"organization","name":"Lyra Therapeutics, Inc.","symbol":"LYRA"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2020-05-01T22:36:04.000Z","date":"2020-04-30","kind":"grant","acquired":true,"shares":14500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable in 36 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following April 30, 2020."}],"balance_after":14500,"derivative":{"exercise_price":16,"expiration_date":"2030-04-29","underlying":"Common Stock","underlying_shares":14500},"source":{"system":"sec-edgar","filing":"0000899243-20-011748","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1239757/000089924320011748/doc4.xml","form_type":"4"}},{"id":3166502,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-30T22:00:40.000Z","date":"2020-04-29","kind":"grant","acquired":true,"shares":18270,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will become fully vested and exercisable on the earlier of April 29, 2021, or the next Annual Meeting of Stockholders, subject to the recipient's continued service."}],"balance_after":18270,"derivative":{"exercise_price":46.37,"expiration_date":"2030-04-29","underlying":"Common Stock","underlying_shares":18270},"source":{"system":"sec-edgar","filing":"0001127602-20-014908","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760220014908/form4.xml","form_type":"4"}},{"id":3392074,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-17T06:01:02.000Z","date":"2019-10-14","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of this option shall vest on December 5, 2015, then in 12 equal quarterly installments thereafter."}],"balance_after":120000,"derivative":{"exercise_price":0.15,"expiration_date":"2025-02-04","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-19-054477","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000110465919054477/a4.xml","form_type":"4"}},{"id":3392073,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-17T06:01:02.000Z","date":"2019-10-14","kind":"sale","acquired":false,"shares":7500,"price":8.5166,"value":63874.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.21 to $8.79, inclusive. The reporting person undertakes to provide to Rubius Therapeutics, Inc., any security holder of Rubius Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-19-054477","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000110465919054477/a4.xml","form_type":"4"}},{"id":3392072,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-17T06:01:02.000Z","date":"2019-10-14","kind":"exercise","acquired":true,"shares":7500,"price":0.15,"value":1125.0,"ownership":{"direct":true},"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001104659-19-054477","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000110465919054477/a4.xml","form_type":"4"}},{"id":3460049,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-17T16:14:34.000Z","date":"2019-07-15","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of this option shall vest on December 5, 2015, then in 12 equal quarterly installments thereafter."}],"balance_after":127500,"derivative":{"exercise_price":0.15,"expiration_date":"2025-02-04","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-19-040757","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000110465919040757/a4.xml","form_type":"4"}},{"id":3460048,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-17T16:14:34.000Z","date":"2019-07-15","kind":"sale","acquired":false,"shares":7500,"price":14.9398,"value":112048.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.70 to $15.42, inclusive. The reporting person undertakes to provide to Rubius Therapeutics, Inc., any security holder of Rubius Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-19-040757","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000110465919040757/a4.xml","form_type":"4"}},{"id":3460047,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-17T16:14:34.000Z","date":"2019-07-15","kind":"exercise","acquired":true,"shares":7500,"price":0.15,"value":1125.0,"ownership":{"direct":true},"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001104659-19-040757","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000110465919040757/a4.xml","form_type":"4"}},{"id":3476047,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-28T20:16:07.000Z","date":"2019-06-27","kind":"grant","acquired":true,"shares":54660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will become fully vested and exercisable on the earlier of June 27, 2020, or the next Annual Meeting of Stockholders, subject to the recipient's continued service."}],"balance_after":54660,"derivative":{"exercise_price":14.34,"expiration_date":"2029-06-27","underlying":"Common Stock","underlying_shares":54660},"source":{"system":"sec-edgar","filing":"0001127602-19-023017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000112760219023017/form4.xml","form_type":"4"}},{"id":3510460,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-28T19:58:33.000Z","date":"2019-05-23","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full on the earlier of (i) the one year anniversary of the grant date or (ii) the date of the next annual meeting of stockholders following the grant date, subject to the recipient's continued service."}],"balance_after":25000,"derivative":{"exercise_price":16.27,"expiration_date":"2029-05-22","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-19-032120","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000110465919032120/a4.xml","form_type":"4"}},{"id":3553971,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-17T20:42:16.000Z","date":"2019-04-15","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of this option shall vest on December 5, 2015, then in 12 equal quarterly installments thereafter."}],"balance_after":135000,"derivative":{"exercise_price":0.15,"expiration_date":"2025-02-04","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-19-022064","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000110465919022064/a4.xml","form_type":"4"}},{"id":3553970,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-17T20:42:16.000Z","date":"2019-04-15","kind":"sale","acquired":false,"shares":7500,"price":17.5732,"value":131799.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.20 to $18.20, inclusive. The Reporting Person undertakes to provide to Rubius Therapeutics, Inc., any security holder of Rubius Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-19-022064","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000110465919022064/a4.xml","form_type":"4"}},{"id":3553969,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-17T20:42:16.000Z","date":"2019-04-15","kind":"exercise","acquired":true,"shares":7500,"price":0.15,"value":1125.0,"ownership":{"direct":true},"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001104659-19-022064","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000110465919022064/a4.xml","form_type":"4"}},{"id":3691879,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-18T16:36:12.000Z","date":"2019-01-14","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of this option shall vest on December 5, 2015, then in 12 equal quarterly installments thereafter."}],"balance_after":142500,"derivative":{"exercise_price":0.15,"expiration_date":"2025-02-04","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001104659-19-002512","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000110465919002512/a4.xml","form_type":"4"}},{"id":3691878,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-18T16:36:12.000Z","date":"2019-01-14","kind":"sale","acquired":false,"shares":7500,"price":14.5925,"value":109443.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.02 to $15.02, inclusive. The reporting person undertakes to provide to Rubius Therapeutics, Inc., any security holder of Rubius Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-19-002512","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000110465919002512/a4.xml","form_type":"4"}},{"id":3691877,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-18T16:36:12.000Z","date":"2019-01-14","kind":"exercise","acquired":true,"shares":7500,"price":0.15,"value":1125.0,"ownership":{"direct":true},"balance_after":7500,"source":{"system":"sec-edgar","filing":"0001104659-19-002512","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000110465919002512/a4.xml","form_type":"4"}},{"id":3732259,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series G Preferred Stock","published_at":"2018-12-13T21:27:22.000Z","date":"2018-12-11","kind":"exercise","acquired":false,"shares":4559,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Series G Preferred Stock (the \"Preferred Stock\") converted into Common Stock based on an applicable conversion ratio of 0.45872 upon the closing of the Issuer's initial public offering on December 11, 2018. The Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series G Preferred Stock (the \"Preferred Stock\") converted into Common Stock based on an applicable conversion ratio of 0.45872 upon the closing of the Issuer's initial public offering on December 11, 2018. The Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Series G Preferred Stock (the \"Preferred Stock\") converted into Common Stock based on an applicable conversion ratio of 0.45872 upon the closing of the Issuer's initial public offering on December 11, 2018. The Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Series G Preferred Stock (the \"Preferred Stock\") converted into Common Stock based on an applicable conversion ratio of 0.45872 upon the closing of the Issuer's initial public offering on December 11, 2018. The Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4559},"source":{"system":"sec-edgar","filing":"0000899243-18-030869","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924318030869/doc4.xml","form_type":"4"}},{"id":3732258,"issuer":{"id":2025,"kind":"organization","name":"Moderna, Inc.","symbol":"MRNA"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-13T21:27:22.000Z","date":"2018-12-11","kind":"exercise","acquired":true,"shares":4559,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Series G Preferred Stock (the \"Preferred Stock\") converted into Common Stock based on an applicable conversion ratio of 0.45872 upon the closing of the Issuer's initial public offering on December 11, 2018. The Preferred Stock had no expiration date."}],"balance_after":11466961,"source":{"system":"sec-edgar","filing":"0000899243-18-030869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1682852/000089924318030869/doc4.xml","form_type":"4"}},{"id":3865401,"issuer":{"id":116417,"kind":"organization","name":"Rubius Therapeutics, Inc.","symbol":"RUBY"},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-18T16:34:01.000Z","date":"2018-07-17","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in equal quarterly installments during the twelve quarters following the grant date."}],"balance_after":25000,"derivative":{"exercise_price":23,"expiration_date":"2028-07-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-18-045776","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709401/000110465918045776/a4.xml","form_type":"4"}},{"id":3892555,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-15T14:50:56.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":12960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 12, 2018 and vests in equal monthly installments until the one-year anniversary of the date of grant and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events."}],"balance_after":12960,"derivative":{"exercise_price":13.73,"expiration_date":"2028-06-11","underlying":"Common Stock","underlying_shares":12960},"source":{"system":"sec-edgar","filing":"0001179110-18-008573","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000117911018008573/edgar.xml","form_type":"4"}},{"id":4253257,"issuer":{"id":7964,"kind":"organization","name":"KALA BIO, Inc."},"owners":[{"id":27758,"kind":"person","name":"LANGER ROBERT","position":1,"cik":"0001239757","reported_name":"LANGER ROBERT","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-21T20:21:52.000Z","date":"2017-07-19","kind":"grant","acquired":true,"shares":12960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted, effective on July 19, 2017 and vests over one year, with 8.33% of the shares underlying the option vesting on August 19, 2017, and an addition 8.33% of the shares underlying the option vesting at the end of each successive one-month period thereafter."}],"balance_after":12960,"derivative":{"exercise_price":15,"expiration_date":"2027-07-18","underlying":"Common Stock","underlying_shares":12960},"source":{"system":"sec-edgar","filing":"0001179110-17-010598","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479419/000117911017010598/edgar.xml","form_type":"4"}}]}